Panagora Asset Management Inc Amneal Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$3.9 - $4.89 $337,790 - $423,537	86,613 Added 109.52%	165,694 $691,000
Q4 2021 Feb 10, 2022	SELL	$3.95 - $5.85 $256,690 - $380,162	-64,985 Reduced 45.11%	79,081 $379,000
Q2 2021 Aug 11, 2021	SELL	$5.12 - $6.82 $162,790 - $216,841	-31,795 Reduced 18.08%	144,066 $738,000
Q1 2021 May 12, 2021	BUY	$4.74 - $7.38 $833,581 - $1.3 Million	175,861 New	175,861 $1.18 Million
Q2 2020 Aug 12, 2020	SELL	$2.87 - $5.46 $306,467 - $583,035	-106,783 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$2.46 - $5.35 $360,508 - $784,031	-146,548 Reduced 57.85%	106,783 $372,000
Q4 2019 Feb 12, 2020	BUY	$2.65 - $5.56 $671,327 - $1.41 Million	253,331 New	253,331 $1.22 Million
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $61,732 - $101,346	-4,716 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.95 - $20.2 $65,788 - $95,263	4,716 New	4,716 $77,000

189

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.31B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.